Ferriprox (Deferiprone) 500 mg Tablet 100's
FERRIPROX (Deferiprone) has been demonstrated to reduce serum ferritin and heart and liver iron.
Serum Ferritin reduction
- In clinical trial 50% of patients experienced at least a 20% reducion in serum ferritin within 1 year of therapy.
Heart iron reduction
- In the clinical trial there was an increae in cardiac MRI T2* from a mean at baseline of 11.8 +/- 4.9 ms to a mean of 15.1 +/- 7.0 ms after approxiamtely one year of treatment.
Liver iron reduction
- In the clinical trial, 42% of patients experience at least 20% reduction in liver within 1 year of therapy.
FORMULATION Deferiprone 500 mg Film-coated Tablet
INDICATION Ferriproxis used in the treatment of iron overload in patients with thalassaemia for whom desferrioxamine is unsuitable.
MANUFACTURER Apotex, Inc. (150 Signet Drive, Toronto, Ontario, Canada, M9L 1T9)
100 pieces per box
For 25 years in the industry, One Pharma stands as one of the most reliable distributors of outstanding quality pharmaceutical and healthcare products in the Philippine market. It has established its presence in key cities nationwide through its progressive deployment of sales and promotions representatives and has been steadily grown in terms of yearly sales turnover and profits.